Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation by Lauren Dautzenberg, Lieke Numan, Wilma Knol, Monica Gianoli, Manon G. van der Meer, Anne-Marie Troost-Oppelaar, Aline F. Westendorp, Marielle H. Emmelot-Vonk, Linda W. van Laake, Huiberdina L. Koek

Get full text